Showing results (31-40 of 463) with videos related to
Sort By:
Pageof 47
Current Opinion in Oncology|November 29, 2007
Restoration of p53 to limit tumor growthWenge Wang, Wafik S El-DeiryCancer Research|September 18, 2004
Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracilShulin Wang, Wafik S El-DeiryAdvances in Experimental Medicine and Biology|April 30, 2008
Regulation of programmed cell death by the p53 pathwayKageaki Kuribayashi, Wafik S El-DeiryNeoplasia (New York, N.Y.)|October 31, 2002
Defining characteristics of Types I and II apoptotic cells in response to TRAILNesrin Ozören, Wafik S El-DeiryInternational Journal of Molecular Sciences|November 13, 2021
Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic AgentsLindsey Carlsen, Wafik S El-DeiryAmerican Journal of Cancer Research|January 11, 2023
Non-canonical approaches to targeting hypoxic tumorsShuai Zhao, Wafik S El-DeiryJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2009
Multispectral fluorescence imagingLanlan Zhou, Wafik S El-DeiryExpert Opinion on Therapeutic Targets|September 8, 2010
TRAIL receptor signaling and therapeuticsJunaid Abdulghani, Wafik S El-DeiryProceedings of the National Academy of Sciences of the United States of America|December 3, 2003
Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapyShulin Wang, Wafik S El-DeiryFrontiers in Oncology|April 12, 2021
Challenges in Diversity, Equity, and Inclusion in Research and Clinical OncologyWafik S El-Deiry, Giuseppe GiacconePageof 47